Anker Announces First Over-the-Counter Hearing Aids at IFA 2026, Potentially Filling Market Void

Anker announced its first over-the-counter (OTC) hearing aids at IFA 2026, according to The Verge. The receiver-in-canal (RIC) design features a main body that rests behind the ear and is powered by Anker's proprietary Thus chip, which was first introduced in the Soundcore Liberty 5 Pro earbuds series earlier this year.

The announcement follows the recent decision by LXE Hearing, parent company of two major US OTC hearing aid brands — Eargo and Lexie Hearing — to wind down its US operations and exit the OTC hearing aid market entirely. This exit has created a potential void in the market that Anker's new product could help fill.

While details on pricing and availability have not been confirmed, Anker's record as a consumer electronics powerhouse suggests the hearing aids could reach a broad audience at a competitive price point.

Why This Matters

Consumer access: The exit of two major OTC brands (Eargo and Lexie) left fewer affordable, non-prescription hearing aid options for millions of Americans with mild to moderate hearing loss.
Market disruption: Anker, known for aggressively pricing consumer electronics, could shake up the OTC hearing aid category by applying its cost-efficient manufacturing and distribution model.
Tech convergence: The use of the Thus chip — originally developed for premium earbuds — signals that hearing assistance features are becoming standard in consumer audio hardware, potentially blurring the line between hearing aids and personal audio devices.

Background

OTC hearing aids became available in the US in 2022 following an FDA rule change designed to lower costs and increase competition. Until recently, the market was dominated by a mix of traditional hearing aid makers and newer entrants like Eargo. The exit of LXE Hearing leaves a gap in retail availability. Anker, best known for chargers and audio accessories under its Soundcore brand, has been building audio expertise for years, including advanced noise cancellation and voice isolation.

Key Perspectives

Consumers with hearing loss: A new OTC option from a well-known brand could mean lower prices and easier access compared to traditional prescription hearing aids, which can cost thousands of dollars. Traditional hearing aid manufacturers (e.g., Sonova, Demant): These companies may face increased price pressure if Anker applies its typical low-margin, high-volume strategy to the hearing aid market. Critics/Skeptics: OTC hearing aids generally offer less customization and professional support than prescription models. Questions remain about whether a consumer electronics company can deliver the clinical-grade sound quality and fitting needed for effective hearing assistance.

What to Watch

Pricing and availability date for Anker's OTC hearing aids, which will determine how competitive they are compared to remaining OTC options.
Consumer and audiologist reviews after launch, particularly regarding sound quality, comfort, and ease of setup.
Regulatory response — whether any US authorities examine the device's safety and efficacy claims as the market restructures.

ZOTPAPER